Brief: Stonepine Capital Reports 9.99% Passive Stake In Aytu Biopharma Shares
June 16 (Reuters) - Aytu Biopharma Inc AYTU.O :
* STONEPINE CAPITAL, L.P. REPORTS 9.99% PASSIVE STAKE IN
AYTU
BIOPHARMA, INC. COMMON STOCK, AS OF JUNE 9, 2023 - SEC FILING
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations